DexCom, Inc. Shares Surged On Upbeat Second Quarter Results

Glucose monitoring systems provider Dexcom, Inc. (DXCM) was one of the biggest gainers on Thursday, with a climb of $29.25, or 30.65% to trade at $124.69.

The gain came after the firm revealed better-than-expected quarterly financial results for the three months ended June 30, 2018.

Net profit jumped 941% to $30.2 million, thanks to significant adoption of continuous glucose monitors (CGMs) that are used by persons with diabetes. Meanwhile, net sales grew 42% to $242.5 million from the same quarter a year ago.

Diabetes patients are increasingly using CGMs to regulate their blood sugar levels. CGMs rely on tiny sensors placed under the skin that regularly harvest and convey data to a separate receiver, which calculates, tracks, and reports blood glucose levels.

DexCom shares have soared 66% since the beginning of the year. The stock has climbed 43% in the last twelve months.

DXCM Earnings & Outlook

(Click on image to enlarge)

DexCom Stock Chart

During the quarter, the San Diego-based company reported a net income of $30.2 million, or 34 cents per share.

In the second quarter of the previous year, the firm had a net income of $2.9 million, or 3 cents per share. After excluding amortization expenses and special items, Dexcom had a loss of 10 cents per share.

Total revenues during the quarter totaled to $242.5 million, versus revenues of $170.6 million in a similar quarter a year ago. Analysts had anticipated adjusted loss of 18 cents per share on sales of $205.8 million, based on figures compiled by Thompson Reuters.

US sale jumped 35% from a year ago, while international sales soared 78% from the previous year. For the full year, the company expects sales of around $925 million, from its previous forecast of $850 million to $860 million.

DexCom CEO Comments

Commenting on the results, DexCom President and Chief Executive Officer Kevin Sayer said, “Q2 was a fantastic quarter for DexCom and demonstrates that CGM adoption is increasing significantly. This performance was particularly notable considering we only began launching our revolutionary G6 platform late in the quarter, and we are pleased to be able to raise our full year growth outlook.”

Disclaimer: This is not meant to be a recommendation to buy or to sell securities nor an offer to buy or sell securities. Before selling or buying any stock or other investment you should consult ...

more
How did you like this article? Let us know so we can better customize your reading experience.

Comments

Leave a comment to automatically be entered into our contest to win a free Echo Show.